StromaForte

N/A

Report date: 2023/10/20 20:06:50

Base Information

Drug NameStromaForte
Drug Alias NameMesenchymal Stem Cell Product(Cellcolabs Clinical Ltd)Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell ProductHuman Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBahamas
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellcolabs Clinical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCellcolabs Clinical Ltd
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A